ask why

Latest research

Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.

Allergy and immunology · J Allergy Clin Immunol Pract · 2026-02-11

Phase 1 open-label crossover RCT in 43 adults with seasonal allergic rhinitis: repeat-dose epinephrine nasal spray (neffy) gave higher or comparable peak levels and faster absorption vs IM epinephrine, including after nasal allergen challenge. All adverse events mild.

RCTn = 43
Oppenheimer et al. Pharmacokinetics and Pharmacodynamics Following Repeat Dosing of neffy (Epinephrine Nasal Spray) Versus Intramuscular Injection During Induced Allergic Rhinitis

Sign in to react

Enter your email and we send a 6-digit code and a link. No password.

Your name and role

These appear beside any methods concern you post and on your profile page.